Senior Scientist, Technology Development
Regeneron Pharmaceuticals
Summary
At Regeneron, we use science and innovation to develop life-changing medicines for people with serious diseases. We are seeking a motivated Senior Scientist to join the Technology Development Team in the Protein Expression Sciences Department, supporting Regeneron's antibody discovery pipeline in an on-site capacity. In this role, you will develop and implement novel high-throughput technologies for rapid antibody generation and functional screening, while collaborating with project teams and department leadership.
Job description
Build our future together
At Regeneron, we use science and innovation to develop life-changing medicines for people with serious diseases. We are seeking a motivated Senior Scientist to join the Technology Development Team in the Protein Expression Sciences Department, supporting Regeneron's antibody discovery pipeline in an on-site capacity. In this role, you will develop and implement novel high-throughput technologies for rapid antibody generation and functional screening, while collaborating with project teams and department leadership.
Discover your role
- Develop methodologies that improve antibody library screening
- Independently design, execute, and refine single-cell assays for antibody discovery
- Engineer and validate high-throughput methods for antibody production
- Analyze, interpret, and present data to project teams and department leadership
- Maintain complete, accurate, and timely records of experiments and data analysis
This role requires
- PhD with 0–3 years of postdoctoral experience, or BS/MS with 4–8 years of experience, in Biochemistry, Bioengineering, Immunology, Molecular Biology, or a related field
- Experience with droplet microfluidics, single-cell assays, and/or cell-free protein expression systems
- Experience with molecular biology techniques such as cloning and NGS library preparation
- Hands-on experience with cell culture and flow cytometry
- Strong problem-solving skills and the ability to work independently and manage multiple projects efficiently
- Excellent communication skills and the ability to thrive in a collaborative, fast-paced environment
Requirements
- PhD with 0–3 years of postdoctoral experience, or BS/MS with 4–8 years of experience, in Biochemistry, Bioengineering, Immunology, Molecular Biology, or a related field
- Experience with droplet microfluidics, single-cell assays, and/or cell-free protein expression systems
- Experience with molecular biology techniques such as cloning and NGS library preparation
- Hands-on experience with cell culture and flow cytometry
- Strong problem-solving skills and the ability to work independently and manage multiple projects efficiently
- Excellent communication skills and the ability to thrive in a collaborative, fast-paced environment
Benefits
- Annual bonuses
- Incentive plans
- Equity awards
- Pension or retirement benefits
- 401(k) company match
- Health and wellness programs
- Fitness centers
- Insurance benefits
- Paid time off
- Family support benefits
Company overview
Regeneron Pharmaceuticals is a leading American biotechnology company founded in 1988 and headquartered in Tarrytown, New York. The company specializes in inventing, developing, and commercializing life-transforming medicines for people with serious diseases. Regeneron is renowned for its innovative antibody technologies and has developed several groundbreaking therapies, including EYLEA® for retinal diseases, DUPIXENT® for inflammatory conditions, and the COVID-19 antibody cocktail REGEN-COV®. The company operates with a strong focus on research and development across multiple therapeutic areas including ophthalmology, oncology, cardiovascular diseases, and rare genetic disorders. Regeneron's proprietary VelocImmune® technology platform enables the rapid generation of fully human monoclonal antibodies. With over 15,000 employees globally and annual revenues exceeding $14 billion, Regeneron has established itself as a major force in the biotechnology industry, consistently ranking among the top-performing pharmaceutical companies and maintaining a robust pipeline of investigational therapies.